Q3 2018 Holdings
Filed 2018-11-14 | 13 holdings | $12.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $12.5M | 674,763 | 98.2% |
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $105.5K | 1,100,000 | 0.8% |
| Merus N V | COM | N5749R100 | $25.6K | 1,295,713 | 0.2% |
| Loxo Oncology Inc | COM | 548862101 | $18.7K | 109,312 | 0.1% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $16.0K | 984,596 | 0.1% |
| Aduro Biotech Inc(ADROEUR) | COM | 00739L101 | $15.5K | 2,105,282 | 0.1% |
| Synlogic Inc | COM | 87166L100 | $14.2K | 998,034 | 0.1% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $11.1K | 1,975,098 | 0.1% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $8.4K | 799,691 | 0.1% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $7.8K | 592,802 | 0.1% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $3.5K | 31,320 | 0.0% |
| Morphosys AG | SPONSORED ADS | 617760202 | $243 | 9,087 | 0.0% |